NRX Pharmaceuticals (NRXP) EPS (Basic) (2017 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly EPS (Basic) of -$0.15 for Q1 2026, up 34.35% year-over-year from -$0.11 in Q1 2025, and up 33.08% quarter-over-quarter from -$0.23 in Q4 2025.
NRX Pharmaceuticals (NRXP) EPS (Basic) (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported EPS (Basic) for 10 consecutive years, with -$0.15 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 34.35% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.55 (up 44.1% YoY), while the FY2025 annual figure was -$3.15, down 33.44% from the prior year.
- EPS (Basic) climbed to -$0.15 in Q1 2026 per NRXP's latest filing, from -$0.23 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.15 in Q1 2026 and bottomed at -$2.62 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.74 across 5 years, with a median of -$0.6 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 98.27% — and 2024, when it slipped 21.88%.
- NRX Pharmaceuticals' EPS (Basic) stood at -$1.56 in 2022, then jumped by 61.71% to -$0.6 in 2023, then soared by 64.01% to -$0.21 in 2024, then retreated by 7.07% to -$0.23 in 2025, then jumped by 33.08% to -$0.15 in 2026.
- Business Quant data shows NRXP's EPS (Basic) at -$0.15 in Q1 2026, -$0.23 in Q4 2025, and -$0.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | 0.18 |
| 10 | NRX Pharmaceuticals | 132.15 Mn | 105.45 Mn | 426,000.00 | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.23 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.23 |
| Dec 31, 2024 | -0.21 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -0.67 |
| Mar 31, 2024 | -0.72 |
| Dec 31, 2023 | -0.60 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -1.10 |
| Mar 31, 2023 | -0.59 |
| Dec 31, 2022 | -1.56 |
| Sep 30, 2022 | -1.37 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -2.62 |
| Dec 31, 2021 | -6.48 |
| Sep 30, 2021 | -7.16 |
| Jun 30, 2021 | -61.34 |